PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.

[1]  M-T Lau,et al.  Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells , 2011, Oncogene.

[2]  M. Taniwaki,et al.  A novel amplification target, ARHGAP5, promotes cell spreading and migration by negatively regulating RhoA in Huh-7 hepatocellular carcinoma cells. , 2009, Cancer letters.

[3]  M. Taniwaki,et al.  ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry , 2009, Genes, chromosomes & cancer.

[4]  G. Hu,et al.  PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma , 2008, FEBS letters.

[5]  H. Döhner,et al.  Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemia , 2007, International journal of cancer.

[6]  J. Squire,et al.  Identification of PFTAIRE protein kinase 1, a novel cell division cycle‐2 related gene, in the motile phenotype of hepatocellular carcinoma cells , 2007, Hepatology.

[7]  J. Squire,et al.  Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma. , 2007, Cancer letters.

[8]  Xin Wang,et al.  Functional characterization of human PFTK1 as a cyclin-dependent kinase , 2007, Proceedings of the National Academy of Sciences.

[9]  Xin Wei Wang,et al.  Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma , 2007, Clinical Cancer Research.

[10]  G. Tseng,et al.  Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas , 2006, Hepatology.

[11]  Adam A. Margolin,et al.  PEG10 is a c-MYC target gene in cancer cells. , 2006, Cancer research.

[12]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[13]  N. Wong,et al.  Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma , 2005, Modern Pathology.

[14]  D. Marchuk,et al.  Human Retroviral gag- and gag-pol-like Proteins Interact with the Transforming Growth Factor-β Receptor Activin Receptor-like Kinase 1*[boxs] , 2005, Journal of Biological Chemistry.

[15]  Youxin Jin,et al.  PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. , 2004, Cellular & molecular immunology.

[16]  Luc Girard,et al.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.

[17]  H. Klocker,et al.  Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: Association with progression and angiogenesis , 2004, The Prostate.

[18]  J. Martinez-Climent,et al.  Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study , 2003, Leukemia.

[19]  S. P. Fodor,et al.  Large-scale genotyping of complex DNA , 2003, Nature Biotechnology.

[20]  Yusuke Nakamura,et al.  Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. , 2003, Cancer research.

[21]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[22]  Chi-Hung Lin,et al.  Comparative genomic hybridization of esophageal squamous cell carcinoma , 2001, Cancer.

[23]  T. Yang,et al.  Identification and cellular localization of human PFTAIRE1. , 2001, Gene.

[24]  T. Kohda,et al.  A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. , 2001, Genomics.

[25]  M. Kusano,et al.  Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy , 2001, Cancer.

[26]  D J Lockhart,et al.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. , 2000, Genome research.

[27]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[28]  J W Gray,et al.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[30]  F. Miglio,et al.  [Epidemiology of hepatocellular carcinoma]. , 1991, Minerva gastroenterologica e dietologica.

[31]  M. Taniwaki,et al.  CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma. , 2008, Cancer genetics and cytogenetics.

[32]  Kenji Nakamura,et al.  Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality , 2006, Nature Genetics.

[33]  Ann-Ping Tsou,et al.  Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. , 2003, Journal of biomedical science.

[34]  M. Yu,et al.  Epidemiology of hepatocellular carcinoma. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.